Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
Rang in aandelen #3557
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
Aandeelprijs
$3.28
Laatst gesynchroniseerd: 2026-07-31
Marktkapitalisatie
$5.10B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-49.70%
Land
TW
Handel Caliway Biopharmaceuticals Co. L (6919)

Categorie

Koersgeschiedenis voor Caliway Biopharmaceuticals Co. L (6919)
Hoogste slotkoers: $3.30 op 2026-07-01

Laagste slotkoers: $0.20 op 2022-12-01
Koersgeschiedenis van Caliway Biopharmaceuticals Co. L van 2022 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$121.62 -12.98%
AU
$768.37 6.79%
CH